Joint pain treatment Surprise residents can plan

What to try for joint pain relief at home

Ease off whatever stirred up the joint, but don’t stop moving for days. Gentle movement keeps the joint from growing stiffer.

A cane may steady you, or an old brace may help if it still fits well. Ask your own doctor or nurse which medicine won’t conflict with your health or prescriptions.

Write down what sets off the ache and how long the joint stays stiff each morning. You’ll have useful details ready if you make an appointment.

Home care has limits, and that’s fair to say. You’ll need an exam when soreness keeps taking away sleep, walking, reaching, or simple chores.

When to have the joint checked

Don’t wait when one joint quickly becomes red, warm, badly swollen, or sharply sore. Get care that day, especially if you also feel ill.

If an injury leaves you unable to stand or bends the joint oddly, seek help now. Urgent care is needed when an arm or leg turns cold or pale, or when sudden weakness keeps the limb from working normally.

Loss of bladder or bowel control may mean a nerve problem in your back. Get urgent help if that happens with new leg weakness or numbness.

For steady soreness, make a regular visit and don’t forget your notes. The exam can find worn joint parts, swelling inside the joint, old injury damage, or soreness that began elsewhere.

Sources

1. In a structured review of 14 studies covering 6,242 patients with an acutely painful swollen joint (653 with confirmed septic arthritis), no single symptom rules the diagnosis in or out: joint pain was present in 85%, a history of joint swelling in 78%, and fever in only 57%. The most powerful bedside data came from aspirating the joint - the summary likelihood ratio rose with the synovial fluid white cell count, from 0.32 below 25,000/microL to 2.9 at 25,000 or more, 7.7 above 50,000 and 28.0 above 100,000.

   Margaretten ME, Kohlwes J, Moore D, Bent S — Does this adult patient have septic arthritis?. JAMA, 2007. DOI: 10.1001/jama.297.13.1478.

2. A EULAR task force of 18 rheumatologists, 3 health professionals, 2 patients and a methodologist defined which joint symptoms, in the absence of any visible swelling, should make a clinician suspect that inflammatory arthritis is coming. Seven parameters survived: symptom duration under one year, symptoms in the knuckle (metacarpophalangeal) joints, morning stiffness lasting 60 minutes or more, symptoms worst in the early morning, a first-degree relative with rheumatoid arthritis, difficulty making a fist, and a positive squeeze test of the knuckles. The combination identified at-risk patients with an area under the ROC curve of 0.92 (95% CI 0.87-0.96).

   van Steenbergen HW, Aletaha D, Beaart-van de Voorde LJJ, et al. — EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis.. Annals of the Rheumatic Diseases, 2017. DOI: 10.1136/annrheumdis-2016-209846.

3. CDC analysis of the 2019-2021 National Health Interview Survey found that in 2021 an estimated 20.9% of US adults (51.6 million people) had chronic pain - pain on most days or every day for three months or more - and 6.9% (17.1 million) had high-impact chronic pain that substantially restricted daily activities. Prevalence was higher among American Indian or Alaska Native adults, adults identifying as bisexual, and adults who are divorced or separated.

   Rikard SM, Strahan AE, Schmit KM, Guy GP Jr — Chronic Pain Among Adults - United States, 2019-2021.. MMWR Morbidity and Mortality Weekly Report, 2023. DOI: 10.15585/mmwr.mm7215a1.

4. In a matched case-control study of 40 early rheumatoid arthritis patients followed for 36 months, those who started DMARD therapy at a median disease duration of 3 months improved significantly more than those who started at 12 months. At study end the DAS28 had improved by 2.8 (SD 1.5) in the very-early group versus 1.7 (SD 1.2) in the late-early group, and radiographic joint destruction by Larsen score progressed significantly more slowly in the very-early group.

   Nell VPK, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS — Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.. Rheumatology (Oxford), 2004. DOI: 10.1093/rheumatology/keh199.